 previous article in this issue | next article in this issue  |
|
Document Details : Title: Treatment at discharge after myocardial infarction in 2,102 patients Subtitle: The PRIMA study Author(s): EXCOFFIER, Sylvie , DE GEVIGNEY, Guy , ECOCHARD, René , RABILLOUD, Muriel , CAO, Danièle , CHENEAU, Edouard , MILON, Hugues , DELAHAYE, François , PRIMA group Journal: Acta Cardiologica Volume: 56 Issue: 1 Date: February 2001 Pages: 17-26 DOI: 10.2143/AC.56.1.2005589 Abstract : Objective— This study sought to examine the use of treatments at discharge in patients hospitalized for myocardial infarction in a French region. Methods and results — Data from 2,102 patients discharged after myocardial infarction were prospectively collected at 48 university, community, and private hospitals in three departments in the Rhône-Alpes region between September 1,1993 and January 31,1995. Beta-blockers were prescribed in 59% of the patients,calcium channel blockers in 22%,nitrates in 59%, antiplatelet agents in 82%,anti-coagulants in 26%, angiotensin-converting enzyme inhibitors in 36%, diuretics in 33%. Beta-blockers were prescribed less often in older patients, and in patients with higher Killip classes or a history of pulmonary disease. Calcium channel blockers were prescribed more often in older patients, and in patients with a history of diabetes, pulmonary disease, or non-Q wave myocardial infarction. Nitrates were prescribed more often in older patients. Angiotensin-converting enzyme inhibitors were prescribed more often in patients with a history of diabetes, hypertension, or anterior myocardial infarction, and less often in patients with a history of renal failure. Diuretics were prescribed more often in older patients, and in patients with a history of renal failure, diabetes, hypertension, or higher Killip classes. Conclusions — There is still underuse of beneficial treatments, particularly in elderly patients. |
